Novartis AG (NVS)
110.66
+1.30
(+1.19%)
USD |
NYSE |
Nov 04, 13:38
Novartis Price: 110.66 for Nov. 4, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 01, 2024 | 109.86 | 110.02 | 109.30 | 109.35 | 1.110M |
| Oct 31, 2024 | 108.46 | 108.83 | 107.94 | 108.40 | 1.399M |
| Oct 30, 2024 | 110.63 | 110.99 | 109.73 | 109.91 | 2.846M |
| Oct 29, 2024 | 111.81 | 112.77 | 109.81 | 110.53 | 3.155M |
| Oct 28, 2024 | 114.28 | 115.76 | 114.16 | 115.63 | 1.603M |
| Oct 25, 2024 | 113.65 | 114.09 | 113.50 | 113.79 | 904084.0 |
| Oct 24, 2024 | 114.08 | 114.24 | 113.12 | 113.13 | 622027.0 |
| Oct 23, 2024 | 113.98 | 114.27 | 113.75 | 114.07 | 1.158M |
| Oct 22, 2024 | 114.16 | 114.54 | 113.93 | 114.32 | 858955.0 |
| Oct 21, 2024 | 116.77 | 116.85 | 115.59 | 115.73 | 646524.0 |
| Oct 18, 2024 | 116.62 | 117.36 | 116.29 | 117.18 | 655649.0 |
| Oct 17, 2024 | 116.51 | 116.72 | 116.08 | 116.51 | 975389.0 |
| Oct 16, 2024 | 116.39 | 116.86 | 116.26 | 116.57 | 620247.0 |
| Oct 15, 2024 | 116.03 | 116.92 | 115.80 | 116.22 | 773584.0 |
| Oct 14, 2024 | 115.92 | 116.44 | 115.89 | 116.30 | 767338.0 |
| Oct 11, 2024 | 115.70 | 116.26 | 115.50 | 116.22 | 1.096M |
| Oct 10, 2024 | 115.64 | 115.71 | 114.58 | 114.81 | 762718.0 |
| Oct 09, 2024 | 115.14 | 115.72 | 114.97 | 115.64 | 1.331M |
| Oct 08, 2024 | 114.12 | 114.19 | 113.55 | 113.77 | 697185.0 |
| Oct 07, 2024 | 114.59 | 114.66 | 113.72 | 113.86 | 1.029M |
| Oct 04, 2024 | 112.88 | 114.03 | 112.80 | 113.95 | 820386.0 |
| Oct 03, 2024 | 115.05 | 115.10 | 113.68 | 113.77 | 1.004M |
| Oct 02, 2024 | 114.28 | 114.52 | 113.81 | 114.47 | 825476.0 |
| Oct 01, 2024 | 115.00 | 115.04 | 114.11 | 114.55 | 912859.0 |
| Sep 30, 2024 | 115.42 | 115.50 | 114.82 | 115.02 | 1.193M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
66.87
Minimum
Mar 23 2020
120.89
Maximum
Aug 30 2024
88.50
Average
85.58
Median
Apr 25 2022
Price Benchmarks
| Amgen Inc | 317.25 |
| AstraZeneca PLC | 71.46 |
| Johnson & Johnson | 158.76 |
| Eli Lilly and Co | 808.00 |
| Merck & Co Inc | 101.37 |
Price Related Metrics
| PE Ratio | 12.97 |
| PS Ratio | 4.544 |
| PEG Ratio | 0.1003 |
| Price to Book Value | 5.107 |
| Price to Free Cash Flow | 18.14 |
| Earnings Yield | 7.71% |
| Market Cap | 221.23B |
| PEGY Ratio | 0.0978 |
| Operating PE Ratio | 16.69 |
| Normalized PE Ratio | 19.28 |